Zhang et al. reveal that Lactobacillus del brueckii ameliorates ulcerative colitis by suppressing proinflammatory macrophages via its surface protein, P4430. This mechanism, which involves targeting the host Mincle receptor, defines a microbial strategy for combating intestinal inflammation and suggests a potential therapeutic path.